Is HLS Therapeutics Inc. (HLTRF) a Buy, Sell, or Hold?
OTC : HLTRF
HLS Therapeutics Inc.
$2.9 USD
-$0.08 (-2.68%)
- Volume
- 200
- Average Volume
- 190
- Market Capitalization
- $90.7M
- P/E Ratio
- -9.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.02
- Year Low
- $2.90
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.00
Company Overview
OTC
Craig Stuart Millian
Drug Manufacturers - Specialty & Generic
Healthcare
HLTRF
85
CA
USD
Liquidity Metrics
0.75
1.00
0.75
0.43
0.00
Sales & Valuation
$56.47M
1.63
1.54
4.93
0.59
Profitability
-$0.4
-$12.65M
-18.42%
-19.19%
-16.54%
-7.82%
P/E Metrics
-9.00
-0.14
-0.14
Analyst Price Target & Rating
2/5
1 Analysts
%
Financial Health Scores
-1.12
5/9
$126.42K
$131.52M
$72.76M
-$4.2M
Key Metrics (TTM)
$124.91M
2.24
7.02
1.00
-16.54%
-3.66%
-11.03%
19.75%
9 days
Company Executives
| Name | Title |
|---|---|
| David Spence | Vice President & Corporate Controller |
| Brian T. Walsh | Chief Commercial Officer |
| Ryan C. Lennox | Senior Vice President of Legal, HR & Compliance and Corporate Secretary |
| Jason A. Gross | Vice President of Scientific Affairs |
| Craig Stuart Millian | Chief Executive Officer & Director |
| John Hanna | Chief Financial Officer & Non-Independent Director |
| Dave Mason | Investor Relations Officer |
Poll Results
No votes yet today — be the first to share your view!
About HLS Therapeutics Inc. (OTC:HLTRF) Stock
HLS Therapeutics Inc. is a specialized pharmaceutical firm engaged in the acquisition and commercialization of medicinal products, with a primary focus on the central nervous system (CNS) and cardiovascular (CV) therapeutic areas. The company's activities extend across Canada, the United States, and international territories. Its core product lineup features Clozaril, an atypical antipsychotic medication prescribed for schizophrenia; Vascepa, composed of icosapent ethyl capsules; and PERSERIS, an injectable risperidone formulation also employed in the treatment of schizophrenia. Beyond pharmaceuticals, HLS Therapeutics offers MyCare psychiatry laboratory assays and MyCare Insite point-of-care diagnostic tests for monitoring drug levels. Additionally, the company possesses U.S. marketing ri ... ghts for Absorica, a commercially available dermatology product, along with Canadian rights for Trinomia, a cardiovascular therapeutic. It also benefits from royalty streams derived from four other healthcare products. HLS Therapeutics Inc. was founded in 2018 and maintains its headquarters in Etobicoke, Canada.
HLS Therapeutics Q1 Earnings Call Highlights
2026-05-16 08:07:13
HLS Therapeutics TSE: HLS reported modest first-quarter revenue growth and reaffirmed its 2026 outlook, while management highlighted early momentum for the company's newly launched cholesterol drug NILEMDO and continued deleveraging of its balance sheet.
Frequently Asked Questions
-
What is the current HLS Therapeutics Inc. (HLTRF) stock price?
-
HLS Therapeutics Inc.(OTC:HLTRF) stock price is $2.9 in the last trading session. During the trading session, HLTRF stock reached the peak price of $4.02 while $2.9 was the lowest point it dropped to. The percentage change in HLTRF stock occurred in the recent session was --2.68% while the dollar amount for the price change in HLTRF stock was -$0.08.
-
HLTRF's industry and sector of operation?
-
The OTC listed HLTRF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of HLTRF?
-
David Spence | Vice President & Corporate Controller
Brian T. Walsh | Chief Commercial Officer
Ryan C. Lennox | Senior Vice President of Legal, HR & Compliance and Corporate Secretary
Jason A. Gross | Vice President of Scientific Affairs
Craig Stuart Millian | Chief Executive Officer & Director -
How many employees does HLTRF have?
-
Number of HLTRF employees currently stands at 85. HLTRF operates from 10 Carlson Court, Etobicoke, ON M9W 6L2, CA.
-
Link for HLTRF official website?
-
Official Website of HLTRF is: https://www.hlstherapeutics.com
-
How do I contact HLTRF?
-
HLTRF could be contacted at phone #+1 416 679 0599 and can also be accessed through its website. HLTRF operates from 10 Carlson Court, Etobicoke, ON M9W 6L2, CA.
-
How many shares of HLTRF are traded daily?
-
The average number of HLTRF shares traded daily for last 3 months was 190.
-
What is the market cap of HLTRF currently?
-
The market value of HLTRF currently stands at $90.7M with its latest stock price at $2.9